DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 205872
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
NDA 205872 describes CISATRACURIUM BESYLATE PRESERVATIVE FREE, which is a drug marketed by Accord Hlthcare, Fresenius Kabi Usa, Jiangsu Hengrui Med, Sandoz Inc, and Somerset Theraps Llc, and is included in five NDAs. It is available from five suppliers. Additional details are available on the CISATRACURIUM BESYLATE PRESERVATIVE FREE profile page.
The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cisatracurium besylate profile page.
Summary for 205872
| Tradename: | CISATRACURIUM BESYLATE PRESERVATIVE FREE |
| Applicant: | Accord Hlthcare |
| Ingredient: | cisatracurium besylate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2MG BASE/ML | ||||
| Approval Date: | Jun 16, 2017 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML | ||||
| Approval Date: | Jun 16, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
